Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Histone H1 isoforms are a family of linker histone proteins fundamental to chromatin structure in eukaryotic cells. Histone H1 is distinct from the core nucleosomal histones (H2A, H2B, H3, H4) and binds to the linker DNA between nucleosomes, stabilizing higher-order chromatin structures and mediating compaction of the genome[1][2][4][5]. In mammals, there are several isoforms (such as H1.0, H1.1, H1.2, H1.3, H1.4, H1.5, testis-specific H1t, oocyte-specific H1oo), which are expressed in various tissues and at different developmental stages[2][5]. H1 proteins feature a globular domain and flexible N- and C-terminal tails important for chromatin interaction and regulation[1][4][6]. They play complex regulatory roles beyond structural support: they modulate chromatin accessibility for regulatory proteins, chromatin remodeling factors, and histone-modifying enzymes[2][4]. Different isoforms may have specialized roles, such as H1.0 in fibroblast activation and fibrosis, and H1.2 in DNA damage sensing and non-homologous end-joining (NHEJ) for double-strand DNA break repair[3][5][7]. Posttranslational modifications—especially phosphorylation—of H1 isoforms are essential for gene expression regulation, the cell cycle, DNA replication, and DNA repair[2][4][7]. Dysregulation or depletion of certain H1 isoforms can alter cell fate, impact cell proliferation and differentiation, and contribute to disease phenotypes (e.g., enhanced tumor progression, fibrosis, impaired DNA repair)[3][5][7]. Histone H1 proteins are essential for viability and development in metazoans, but are generally not considered classic direct drug targets or receptors; rather, they are structural and regulatory components of chromatin architecture[1][2][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Histone H1 isoform (Histone H1).